Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study

@inproceedings{Kim2015InfliximabVC,
  title={Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study},
  author={Eun Hye Kim and Duk Hwan Kim and Soo Jung Park and Sung Pil Hong and Tae Il Kim and Won Kim and Jae Hee Cheon},
  booktitle={Gut and liver},
  year={2015}
}
BACKGROUND/AIMS In patients with corticosteroid-refractory ulcerative colitis (UC), cyclosporine or infliximab may be added to the treatment regimen to induce remission. Here, we aimed to compare the efficacy of cyclosporine and infliximab. METHODS Between January 1995 and May 2012, the medical records of 43 patients with corticosteroid-refractory UC who received either infliximab or cyclosporine as a rescue therapy at a tertiary care hospital in Korea were reviewed. RESULTS Among the 43… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Similar Papers

Loading similar papers…